Sarcomatoid urothelial carcinoma in a bladder diverticulum: first report of an unusual case.
DOI:
https://doi.org/10.54361/Keywords:
Urinary bladder, Sarcomatoid urothelial carcinomaAbstract
70-year-old Libyan man presented with abdominal distension and gross hematuria. Cystescopy showed diverticulum in urinary bladder with tumor arising from its lateral wall. The tumor was composed of conventional urothelial carcinoma with sarcomatoid features. The clinical presentation and management are being discussed.
Downloads
References
Wright JL, Black PC, Brown GA, et al. (2007) Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J. Urol. 178, 6: 2302-6.
Eble JN, Sauter G, Epstein JI, Sesterhenn I (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press: Lyon.
Zhai QJ, Black J, Ayala AG, Ro JY (2007) Histologic variants of infiltrating urothelial carcinoma. Arch Pathol Lab Med. 131: 1244-56.
Sung MT, Wang M, MacLennan GT, et al. (2007) Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation Journal of Pathology, vol. 211, no. 4, pp. 420–430,
Kodzo A, Venyo G & Titi S (2014) Sarcomatoid Variant of Urothelial Carcinoma (Carcinosarcoma, Spindle Cell Carcinoma): A Review of the Literature Urology 9 pages. Article ID 794563.
Kanno J, Sakamoto A, Washizuka M, Kawai T, Kasuga T (1985) Malignant mixed mesodermal tumor of bladder occurring after radiotherapy for cervical cancer: report of a case. J Urol. 133, 5:854-6.
Lopez-Beltran A, Pacelli A, Rothenberg HJ et al. (1998) Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol. 159, 5:1497-503.
Armah HB, Parwani AV (2007) Sarcomatoid urothelial carcinoma with choriocarcinomatous features: first report of an unusual case. Urology 70, 4: 11-14.
Hejtmancik JH, Klatt WW (1960) Co-existing carcinoma and sarcoma of the bladder. J Urol. 84:320–321.
Holtz F, Fox JE, Abell MR (1972) Carcinosarcoma of the urinary bladder. Cancer 29: 294–304.
Armstrong A, Wang M, Eble J et al. (2009) TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Modern Pathology 22: 113–118.
Kishore TA, Bhat S, Albert AS, Augustine J (2005) A sarcomatoid carcinoma in a bladder diverticulum: A rare case. Indian J Med Sci. 59,10: 535-555.
Black P. C, Brown GA., and. Dinney CN et al. (2009) “The impact of variant histology on the outcome of bladder cancer treated with curative intent,” Urologic Oncology 27, 1: 3– 7.
Bansal A, Kumar N, Suresh C. Sharma SC (2013) Sarcomatoid variant of urothelial carcinoma of the urinary bladder. Journal of Cancer Research and Therapeutics 9, 4: 571-573.
Wang J, Wang F, LaGrange C et al. (2010) Clinical features of sarcomatoid carcinoma ( carcinosarcoma) of the urinary bladder: Analysis of 221 cases. Hindawi Publishing Corporation Sarcoma 7 pages, Article ID 454792.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 L. S. Elbarghati , L. M. Azzouz, W.M Alsarraj (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
